A verification study of the suppressive effect of the test food consumption on the elevation of postprandial blood glucose: a randomized, placebo-controlled, double-blind, crossover comparison study - A verification study of the suppressive effect of the test food consumption on the elevation of postprandial blood glucose

ORTHOMEDICO Inc.0 sites48 target enrollmentNovember 9, 2023

Overview

No summary available.

Registry

who.int

Start Date

November 9, 2023

End Date

February 11, 2024

Last Updated

last year

Study Type

Interventional

Sex

All

Sponsor

•1\. Individuals who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2\. Individuals who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3\. Individuals currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, chronic kidney disease, cerebrovascular disorder, rheumatic disease, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4\. Individuals who use or take "Foods for Specified Health Uses" or "Foods with Functional Claims" 5\. Individuals who take medications (including herbal medicines) and supplements 6\. Individuals who are allergic to medicines, the test food related products, tea, wheat, milk ingredients, eggs, and/or soybeans 7\. Individuals who are pregnant, lactating, or planning to become pregnant during this study 8\. Individuals who have been enrolled in other clinical studies within the last 28 days before the agreement to participate in this study or plan to participate another study during this study 9\. Individuals who are judged as ineligible to participate in this study by the physician 10\. Individuals whose physical condition is impaired easily by caffeine